vs

Side-by-side financial comparison of CME Group (CME) and Dover Corporation (DOV). Click either name above to swap in a different company.

Dover Corporation is the larger business by last-quarter revenue ($2.1B vs $1.9B, roughly 1.1× CME Group). Dover Corporation runs the higher net margin — 13.4% vs 0.1%, a 13.4% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 12.5%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -1.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Dover Corporation is an American conglomerate manufacturer of industrial products. The Downers Grove, Illinois-based company was founded in 1955. As of 2021, Dover's business was divided into five segments: Engineered Products, Clean Energy and Fueling, Imaging & Identification, Pumps & Process Solutions and Climate and Sustainability Technologies. Dover is a constituent of the S&P 500 index and trades on the New York Stock Exchange under the symbol DOV. Dover was ranked 448 in the 2024 Fortu...

CME vs DOV — Head-to-Head

Bigger by revenue
DOV
DOV
1.1× larger
DOV
$2.1B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+2.0% gap
CME
14.5%
12.5%
DOV
Higher net margin
DOV
DOV
13.4% more per $
DOV
13.4%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-1.8%
DOV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
DOV
DOV
Revenue
$1.9B
$2.1B
Net Profit
$1.2M
$282.1M
Gross Margin
39.1%
Operating Margin
0.1%
16.5%
Net Margin
0.1%
13.4%
Revenue YoY
14.5%
12.5%
Net Profit YoY
20.7%
22.2%
EPS (diluted)
$2.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
DOV
DOV
Q1 26
$1.9B
$2.1B
Q4 25
$1.6B
$2.1B
Q3 25
$1.5B
$2.1B
Q2 25
$1.7B
$2.0B
Q1 25
$1.6B
$1.9B
Q4 24
$1.5B
$1.5B
Q3 24
$1.6B
$2.0B
Q2 24
$1.5B
$2.2B
Net Profit
CME
CME
DOV
DOV
Q1 26
$1.2M
$282.1M
Q4 25
$1.2B
$282.1M
Q3 25
$908.0M
$302.0M
Q2 25
$1.0B
$279.1M
Q1 25
$956.2M
$230.8M
Q4 24
$874.6M
$1.4B
Q3 24
$912.8M
$347.1M
Q2 24
$883.2M
$281.8M
Gross Margin
CME
CME
DOV
DOV
Q1 26
39.1%
Q4 25
39.1%
Q3 25
40.1%
Q2 25
39.9%
Q1 25
40.0%
Q4 24
41.4%
Q3 24
38.5%
Q2 24
37.7%
Operating Margin
CME
CME
DOV
DOV
Q1 26
0.1%
16.5%
Q4 25
61.8%
16.5%
Q3 25
63.3%
18.2%
Q2 25
66.7%
17.3%
Q1 25
67.5%
15.9%
Q4 24
62.1%
14.0%
Q3 24
64.6%
16.8%
Q2 24
65.3%
17.0%
Net Margin
CME
CME
DOV
DOV
Q1 26
0.1%
13.4%
Q4 25
71.7%
13.4%
Q3 25
59.1%
14.5%
Q2 25
60.6%
13.6%
Q1 25
58.2%
12.4%
Q4 24
57.3%
96.4%
Q3 24
57.6%
17.5%
Q2 24
57.6%
12.9%
EPS (diluted)
CME
CME
DOV
DOV
Q1 26
$2.06
Q4 25
$3.24
$2.06
Q3 25
$2.49
$2.19
Q2 25
$2.81
$2.02
Q1 25
$2.62
$1.67
Q4 24
$2.40
$10.38
Q3 24
$2.50
$2.51
Q2 24
$2.42
$2.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
DOV
DOV
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$3.4B
$3.3B
Stockholders' EquityBook value
$7.4B
Total Assets
$202.0B
$13.4B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
DOV
DOV
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
DOV
DOV
Q1 26
$3.4B
$3.3B
Q4 25
$3.3B
Q3 25
$3.1B
Q2 25
$3.1B
Q1 25
$3.0B
Q4 24
$2.9B
Q3 24
$3.0B
Q2 24
$3.0B
Stockholders' Equity
CME
CME
DOV
DOV
Q1 26
$7.4B
Q4 25
$28.7B
$7.4B
Q3 25
$28.2B
$7.7B
Q2 25
$27.7B
$7.4B
Q1 25
$27.0B
$7.1B
Q4 24
$26.5B
$7.0B
Q3 24
$28.2B
$5.7B
Q2 24
$27.6B
$5.4B
Total Assets
CME
CME
DOV
DOV
Q1 26
$202.0B
$13.4B
Q4 25
$198.4B
$13.4B
Q3 25
$187.1B
$13.4B
Q2 25
$179.9B
$13.2B
Q1 25
$157.8B
$12.6B
Q4 24
$137.4B
$12.5B
Q3 24
$137.8B
$11.9B
Q2 24
$123.4B
$11.3B
Debt / Equity
CME
CME
DOV
DOV
Q1 26
0.45×
Q4 25
0.45×
Q3 25
0.40×
Q2 25
0.41×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.53×
Q2 24
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons